New Blood-Based Biomarker Identified for Detecting Asymptomatic Lynch Syndrome Carriers

Researchers at The University of Texas MD Anderson Cancer Center have identified a new blood-based biomarker that may help detect asymptomatic carriers of Lynch Syndrome (LS), according to findings published in *Nature Communications*. Lynch Syndrome is a hereditary condition linked to an increased risk of developing certain cancers, including colorectal and endometrial cancer. This discovery could provide valuable insights into early detection and monitoring for individuals with LS.

The study focused on identifying biomarkers in the blood that could signal the presence of LS before symptoms appear. Researchers utilized advanced methodologies to pinpoint specific markers associated with the genetic condition. Lynch Syndrome is caused by inherited mutations in DNA mismatch repair genes, which significantly elevate cancer risk. Early identification of carriers through non-invasive methods like blood tests could aid in preventive measures and tailored medical care for those at higher risk.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 6, 2026

Author

GOAI